| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C0033147> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C0042742> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C3658241> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C3658242> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C3658243> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C3713756> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C5387588> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C5391442> <https://research.tib.eu/covid-19/entity/35361754_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Sanofi, Marcy l\'Etoile, France.\', \'Sanofi, Cambridge, MA, USA.\', \'GSK, Rixensart, Belgium.\', \'GSK, Wavre, Belgium.\', \'Sanofi, Marcy l\'Etoile, France. valerie.lecouturier@sanofi.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Anosova_Natalie_G> <https://research.tib.eu/covid-19/entity/Berry_Catherine> <https://research.tib.eu/covid-19/entity/Chicz_Roman_M> <https://research.tib.eu/covid-19/entity/Gautheron_Sylviane> <https://research.tib.eu/covid-19/entity/Gutzeit_Cindy> <https://research.tib.eu/covid-19/entity/Huang_Dean> <https://research.tib.eu/covid-19/entity/Kishko_Michael> <https://research.tib.eu/covid-19/entity/Koutsoukos_Marguerite> <https://research.tib.eu/covid-19/entity/Lecouturier_Valerie> <https://research.tib.eu/covid-19/entity/Pavot_Vincent> <https://research.tib.eu/covid-19/entity/Raillard_Alice> <https://research.tib.eu/covid-19/entity/Tibbitts_Tim>
?:doi	10.1038/s41467-022-29219-2
?:doi	<https://research.tib.eu/covid-19/entity/10.1038/s41467-022-29219-2>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Nature communications
is ?:pmid of	<https://research.tib.eu/covid-19/entity/35361754>
?:pmid	<https://research.tib.eu/covid-19/entity/35361754>
?:pmid	35361754
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	6.582
?:rankingScore_hIndex	198
?:title	Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/35361754>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/35361754>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all